Dec 14th, 2018

How Bio Startup Zymergen Plans to Spend $400M

Zymergen Inc. Chief Executive Officer Joshua Hoffman discusses the biotechnology research firm's plans to utilize therecent $400 million round of investment in the startup. He speaks with Bloomberg's Emily Chang on "Bloomberg Technology." (Source: Bloomberg)

Top Video

Explore More

Duration:23:44

Blackstone’s Gray on $26 Bln Bet That Felt 'Career Shortening'

Leaders with Francine Lacqua

Duration:1:48

Oil Jumps as Trump Rebuffs Iran’s Offer

Daybreak: Europe

Duration:3:08

US Citizens From Hantavirus Ship Isolated in Nebraska

Duration:2:40

Trump, Xi Slated for Beijing Summit

Duration:2:52

JPMorgan Says Equities at All-Time Highs 'Make Sense'

Duration:2:24

Brent Has Found an 'Uneasy Equilibrium,' StanChart Says

Duration:1:37

Starmer's UK Leadership Woes Add to Gilt Risks, Rabobank Says

Duration:1:50

Morgan Stanley’s Hornback Expects a ‘Spicier’ US Inflation Report

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.